1 – 10 of 14
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept : Results from the international TOCERRA and PANABA observational collaborative studies
(
- Contribution to journal › Article
-
Mark
Impact of patient characteristics on ASDAS disease activity state cut-offs in axial spondyloarthritis : results from nine European rheumatology registries
(
- Contribution to journal › Article
-
Mark
EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis : 2023 update
2024) In Annals of the Rheumatic Diseases(
- Contribution to journal › Article
-
Mark
Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis : a European routine-care observational study
(
- Contribution to journal › Article
- 2023
-
Mark
Sex differences in the effectiveness of first-line tumour necrosis factor inhibitors in axial spondyloarthritis : Results from the EuroSpA Research Collaboration Network
(
- Contribution to journal › Article
- 2022
-
Mark
Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors : Data from the EuroSpA collaboration
(
- Contribution to journal › Article
- 2019
-
Mark
Imputing missing data of function and disease activity in rheumatoid arthritis registers : What is the best technique?
(
- Contribution to journal › Article
- 2018
-
Mark
Non-pharmacological Effects in Switching Medication : The Nocebo Effect in Switching from Originator to Biosimilar Agent
(
- Contribution to journal › Article
- 2017
-
Mark
Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the “pan-European registry collaboration for abatacept (PANABA)
(
- Contribution to journal › Article
- 2013
-
Mark
EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis
(
- Contribution to journal › Article